Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth B Coffelt

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|March 15, 2021
Neutrophil dynamics in the tumor microenvironmentAmanda J McFarlane, Frédéric Fercoq, Seth B Coffelt, et al.
IEEE Open Journal of Engineering in Medicine and Biology|July 11, 2022
Assessment of CAR-T Cell-Mediated Cytotoxicity in 3D Microfluidic Cancer Co-Culture Models for Combination TherapyKarla Paterson, Sarah Paterson, Theresa Mulholland, et al.
Immunological Reviews|August 26, 2020
Gut γδ T cells as guardians, disruptors, and instigators of cancerToshiyasu Suzuki, Liam Hayman, Anna Kilbey, et al.
Plos One|June 30, 2012
Toll-like receptor 3 and suppressor of cytokine signaling proteins regulate CXCR4 and CXCR7 expression in bone marrow-derived human multipotent stromal cellsSuzanne L Tomchuck, Sarah L Henkle, Seth B Coffelt, et al.
Mediators of Inflammation|October 12, 2016
Macrophages and Neutrophils: Regulation of the Inflammatory Microenvironment in Autoimmunity and CancerMichal A Rahat, Seth B Coffelt, Zvi Granot, et al.
Trends in Immunology|March 28, 2026
Seven subsets, two fates: mouse γδ T cells in cancer immunityAbhiram C T Mallu, Natalie Z Phinney, Federico Lupo, et al.
Journal of Circadian Rhythms|March 13, 2008
Period-2: a tumor suppressor gene in breast cancerShulin Xiang, Seth B Coffelt, Lulu Mao, et al.
Frontiers in Immunology|December 17, 2020
Editorial: γδ T Cells in CancerSeth B Coffelt, Dieter Kabelitz, Bruno Silva-Santos, et al.
Molecular Cancer Research : MCR|June 4, 2009
Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cellsSeth B Coffelt, Suzanne L Tomchuck, Kevin J Zwezdaryk, et al.
Trends in Cancer|December 10, 2019
Tumour Dormancy and Reawakening: Opportunities and ChallengesAdrienne Boire, Seth B Coffelt, Sergio A Quezada, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|March 15, 2021
Neutrophil dynamics in the tumor microenvironmentAmanda J McFarlane, Frédéric Fercoq, Seth B Coffelt, et al.
IEEE Open Journal of Engineering in Medicine and Biology|July 11, 2022
Assessment of CAR-T Cell-Mediated Cytotoxicity in 3D Microfluidic Cancer Co-Culture Models for Combination TherapyKarla Paterson, Sarah Paterson, Theresa Mulholland, et al.
Immunological Reviews|August 26, 2020
Gut γδ T cells as guardians, disruptors, and instigators of cancerToshiyasu Suzuki, Liam Hayman, Anna Kilbey, et al.
Plos One|June 30, 2012
Toll-like receptor 3 and suppressor of cytokine signaling proteins regulate CXCR4 and CXCR7 expression in bone marrow-derived human multipotent stromal cellsSuzanne L Tomchuck, Sarah L Henkle, Seth B Coffelt, et al.
Mediators of Inflammation|October 12, 2016
Macrophages and Neutrophils: Regulation of the Inflammatory Microenvironment in Autoimmunity and CancerMichal A Rahat, Seth B Coffelt, Zvi Granot, et al.
Trends in Immunology|March 28, 2026
Seven subsets, two fates: mouse γδ T cells in cancer immunityAbhiram C T Mallu, Natalie Z Phinney, Federico Lupo, et al.
Journal of Circadian Rhythms|March 13, 2008
Period-2: a tumor suppressor gene in breast cancerShulin Xiang, Seth B Coffelt, Lulu Mao, et al.
Frontiers in Immunology|December 17, 2020
Editorial: γδ T Cells in CancerSeth B Coffelt, Dieter Kabelitz, Bruno Silva-Santos, et al.
Molecular Cancer Research : MCR|June 4, 2009
Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cellsSeth B Coffelt, Suzanne L Tomchuck, Kevin J Zwezdaryk, et al.
Trends in Cancer|December 10, 2019
Tumour Dormancy and Reawakening: Opportunities and ChallengesAdrienne Boire, Seth B Coffelt, Sergio A Quezada, et al.
Pageof 7